- Bowen, A.C., Tong S.Y.C., Andrews, R.M., O’Meara, I.M, McDonald, M.I., Chatfield, M.D., Currie B.J., & Carapetis, J.R. (2014). Short course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. The Lancet, early online publication 27 August 2014. doi:10.1016/S0140-6736(14)60841-2
- Bowen, A.C., Lilliebridge, R.A., Tong, S.Y., Baird, R.W., Ward, P., McDonald, M.I., et al. (2012). Is Streptococcus pyogenes Resistant or Susceptible to Trimethoprim-Sulfamethoxazole? Journal of Clinical Microbiology, 50(12),4067-72.
- Bowen, A.C., Tong, S.Y., Carapetis, J.R. (2013). Reply to "Susceptibility of Streptococcus pyogenes to trimethoprim-sulfamethoxazole". Journal of Clinical Microbiology, 51(4),1351.
- Bowen, A.C., Tong, S.Y., Chatfield, M.D., Andrews, R.M., Carapetis, J.R. (2013). Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. Royal Society of Tropical Medicine and Hygiene, 107(6), 384-9.
- Tong, S.Y., Andrews, R.M., Kearns, T., Gundjirryirr, R., McDonald, M.I., Currie, .B.J, et al. (2010). Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial. Journal of Paediatrics and Child Health, 46(3),131-3.